Milestone Pharmaceuticals MIST

$ 1.77 3.21%

Quarterly report 2024-Q3
added 11-12-2024

Milestone Pharmaceuticals Balance Sheet 2011-2024 | MIST

Annual Balance Sheet Milestone Pharmaceuticals

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	36.6 M	-5.14 M	-113 M	-71.4 M	-119 M	-85.9 M	-10.9 M	-	-	-	-	-	-
Long Term Debt	49.8 M	2 M	474 K	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	546 K	495 K	224 K	245 K	330 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	696 K	184 K	139 M	59.1 M	-	-	-	-	-	-
Total Current Liabilities	7.23 M	6.14 M	6.78 M	6.16 M	8.33 M	4.53 M	-	-	-	-	-	-	-
Total Liabilities	58.5 M	8.14 M	7.25 M	6.86 M	8.51 M	143 M	60.7 M	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-326 M	-266 M	-208 M	-163 M	-113 M	-58.3 M	-35.1 M	-	-	-	-	-	-
Total Assets	75.2 M	74.5 M	120 M	150 M	123 M	88.1 M	27.6 M	-	-	-	-	-	-
Cash and Cash Equivalents	13.8 M	7.64 M	114 M	72.3 M	120 M	85.9 M	10.9 M	-	-	-	-	-	-
Book Value	16.8 M	66.3 M	113 M	143 M	115 M	-55.2 M	-33.1 M	-	-	-	-	-	-
Total Shareholders Equity	16.8 M	66.3 M	113 M	143 M	115 M	83.5 M	26 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Milestone Pharmaceuticals

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	52.4 M	51.5 M	50.6 M	49.8 M	48.9 M	48.1 M	47.3 M	2 M	2.09 M	384 K	433 K	474 K	512 K	573 K	635 K	696 K	696 K	696 K	696 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	58.7 M	57.3 M	56.1 M	58.5 M	58.6 M	56.6 M	57.1 M	8.14 M	8.61 M	4.64 M	5.04 M	7.25 M	6.36 M	5.9 M	6.45 M	6.86 M	6.86 M	6.86 M	6.86 M	8.51 M	8.51 M	8.51 M	8.51 M	4.53 M	4.53 M	4.53 M	4.53 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-355 M	-346 M	-336 M	-326 M	-312 M	-297 M	-281 M	-266 M	-252 M	-237 M	-220 M	-206 M	-189 M	-175 M	-176 M	-163 M	-163 M	-163 M	-163 M	-113 M	-113 M	-113 M	-113 M	-58.3 M	-58.3 M	-58.3 M	-58.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	82.7 M	89.2 M	96 M	75.2 M	87.1 M	97 M	111 M	74.5 M	85.8 M	91.3 M	106 M	120 M	134 M	145 M	138 M	150 M	150 M	150 M	150 M	123 M	123 M	123 M	123 M	88.1 M	88.1 M	88.1 M	88.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	12.8 M	13.3 M	10.1 M	13.8 M	9.88 M	32.6 M	74 M	7.64 M	37.3 M	63.2 M	92.2 M	114 M	111 M	97.8 M	71.9 M	72.3 M	72.3 M	72.3 M	72.3 M	120 M	120 M	120 M	120 M	85.9 M	85.9 M	85.9 M	85.9 M	10.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	24 M	32 M	39.9 M	16.8 M	28.5 M	40.4 M	53.9 M	66.3 M	77.2 M	86.7 M	101 M	113 M	127 M	140 M	132 M	143 M	143 M	143 M	143 M	115 M	115 M	115 M	115 M	83.5 M	83.5 M	83.5 M	83.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	24 M	32 M	39.9 M	16.8 M	28.5 M	40.4 M	53.9 M	66.3 M	77.2 M	86.7 M	101 M	113 M	127 M	140 M	132 M	143 M	143 M	143 M	143 M	115 M	115 M	115 M	115 M	83.5 M	-55.2 M	-55.2 M	-55.2 M	26 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency